Healthy participants.
Healthy practice.

The World Health Organization (WHO) estimates that more than 1.4 billion adults over age of 20 are overweight, and that the conditions of being overweight and obese are the fifth leading risk for global deaths. Additionally, the WHO reports that 44% of the diabetes burden, 23% of the ischaemic heart disease burden and between 7% and 41% of certain cancer burdens are attributable to being overweight or obese.*

The need to combat this growing global issue is clear, and at Medifast, our vision is to create health, hope, and a greater quality of life for individuals through meal replacement products that assist in their weight-loss journey.


Medifast began in 1980 as a doctor-prescribed weight-loss program using liquid meal replacements, which medical professionals kept in their cabinets. But our product choices soon outgrew those cabinets, and demand for consumer access was great.

Fast forward thirty years to the Medifast of today. We have an excellent reputation and track record of success in the U.S., and are now excited to have the opportunity to partner with health care professionals in Canada where permitted by law. Medifast’s nutrition-based program can help your participants control their weight and improve their health.

The Medifast 5 & 2 & 2 Plan is designed to help your participants work toward their weight-loss goals. We recommend that participants discuss any medical conditions, medications (including vitamin and/or mineral supplements), and weight-loss plans with their health care provider before starting the Medifast Program. Women who are pregnant or breastfeeding/nursing should not use the Medifast Program. Participants that currently have or have had cardiovascular disease, bariatric surgery, hypertension, cancer, diabetes, liver disease, or a condition that requires them to follow a modified diet plan, should consult with their health care provider before use. Participants should not use if they currently have an eating disorder (e.g. anorexia, bulimia), gout, or kidney disease or have been medically advised to follow a low-protein diet. Participants taking diabetes, thyroid or blood thinner medication (e.g. Coumadin), should consult with their health care provider before use.

* World Health Organization, Obesity and Overweight, Fact sheet Number 311, March 2013